These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39243555)

  • 1. Identification of a nomogram predicting overall survival based on ADAP2-related apoptosis genes in gliomas.
    Zhang C; Wang J; Niu Z; Zhang K; Wang C; Wang S; Hou S; Yu D; Lin N
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113084. PubMed ID: 39243555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas.
    Wu Y; Peng Z; Gu S; Wang H; Xiang W
    Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cuproptosis-based prognostic model for predicting survival in low-grade glioma.
    Zhao Z; Ma Y; Liu Y; Chen Z; Zheng J
    Aging (Albany NY); 2024 May; 16(10):8697-8716. PubMed ID: 38738989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel NFAT1-IL6/JAK/STAT3 signaling pathway related nomogram predicts overall survival in gliomas.
    Zhang C; Wang Y; Shao W; Zhou D; Yu D; Hou S; Lin N
    Sci Rep; 2023 Jul; 13(1):11401. PubMed ID: 37452092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-κB signaling.
    Li J; Xu H; Wang Q; Fu P; Huang T; Anas O; Zhao H; Xiong N
    Cancer Med; 2019 May; 8(5):2288-2302. PubMed ID: 30848088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning-based identification of a cell death-related signature associated with prognosis and immune infiltration in glioma.
    Zhou Q; Wu F; Zhang W; Guo Y; Jiang X; Yan X; Ke Y
    J Cell Mol Med; 2024 Jun; 28(11):e18463. PubMed ID: 38847472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma.
    Dai J; Gao J; Dong H
    Aging (Albany NY); 2024 Jun; 16(14):11162-11184. PubMed ID: 39012280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable screening and model construction for prognosis of elderly patients with lower-grade gliomas based on LASSO-Cox regression: a population-based cohort study.
    Niu X; Chang T; Zhang Y; Liu Y; Yang Y; Mao Q
    Front Immunol; 2024; 15():1447879. PubMed ID: 39324140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma.
    Qu S; Chen Z; Liu B; Liu J; Wang H
    Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
    Liu J; Li G
    Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a nomogram to predict overall survival in patients with glioma: a population-based study.
    Huang W; Lei Y; Cao X; Xu G; Wang X
    Aging (Albany NY); 2024 Jul; 16(13):10905-10917. PubMed ID: 38970773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas.
    Zheng Y; Ji Q; Xie L; Wang C; Yu CN; Wang YL; Jiang J; Chen F; Li WB
    J Cell Mol Med; 2021 Mar; 25(6):3080-3090. PubMed ID: 33594759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a nomogram for prognostic prediction of lower-grade glioma based on alternative splicing signatures.
    Wang Y; Wang Z; Zhao B; Chen W; Wang Y; Ma W
    Cancer Med; 2020 Dec; 9(24):9266-9281. PubMed ID: 33047900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLEKHG5 is a novel prognostic biomarker in glioma patients.
    Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
    Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.